Tumor-Released Microvesicles as Vehicles of Immunosuppression
Open Access
- 1 April 2007
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 67 (7) , 2912-2915
- https://doi.org/10.1158/0008-5472.can-07-0520
Abstract
Tumor-released microvesicles, or exosomes, which are abundant in the body fluids of patients with cancer, are likely to be involved in tumor progression. We recently showed that microvesicles released by human melanoma and colorectal carcinoma cells can promote the differentiation of monocytes to myeloid-derived suppressor cells which support tumoral growth and immune escape. These findings underscore an important role for these extracellular organelles in remodeling tumor-stromal interactions to promote malignancy. [Cancer Res 2007;67(7):2912–5]Keywords
This publication has 22 references indexed in Scilit:
- TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathwayJournal of Cell Science, 2006
- Human Tumor-Released Microvesicles Promote the Differentiation of Myeloid Cells with Transforming Growth Factor-β–Mediated Suppressive Activity on T LymphocytesCancer Research, 2006
- Induction of Tolerance by Exosomes and Short-Term Immunosuppression in a Fully MHC-Mismatched Rat Cardiac Allograft ModelAmerican Journal of Transplantation, 2006
- Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomasProceedings of the National Academy of Sciences, 2006
- Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppressionPublished by Elsevier ,2005
- Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?Expert Opinion on Biological Therapy, 2005
- Exosomes and the MICA-NKG2D system in cancerBlood Cells, Molecules, and Diseases, 2005
- Mechanisms and functional significance of tumour-induced dendritic-cell defectsNature Reviews Immunology, 2004
- Effect of Proton Pump Inhibitor Pretreatment on Resistance of Solid Tumors to Cytotoxic DrugsJNCI Journal of the National Cancer Institute, 2004
- "Tolerosomes" are produced by intestinal epithelial cellsEuropean Journal of Immunology, 2001